U.S. Markets open in 9 hrs 26 mins

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.580.00 (0.00%)
At close: 4:00PM EDT
People also watch
EBIOHTBXMRNSZSANEYEG
  • A
    Anonymous
    Anonymous
    idiots. it's still far below where it was only a week ago.
  • S
    Stock_itch
    Stock_itch
    I'm back, as promised, from when this was $3.00. Was adding today, and will add all week. Great ER, FDA approval info, and the fact that they won't have to issue an offering before product release. Hilda is still here? He-she has worn out their welcome, it's EVOK time to run back up to $3+

    .
  • Y
    Yahoo Reader
    Yahoo Reader
    Unfortunately Hilda may be right

    once THIS STOCK looses steam it is usually a pullback.
    take the bump, wait for it to recind then go back in ?
    A
  • E
    Edward
    Edward
    Going up Great stock moving
  • p
    peter
    peter
    Low volume, hedge funds got their butts handed to them are hesitating... I'm so proud of this company. Have to content with small gains but it is totally worth it. How many companies who flunked trial 3 then defaulted on their last million, was nake shorted, left for dead and came back with money in the bank? This is great!
  • D
    Doc
    Doc
    Hilda. We all held our long position stance on down days. Where r u today? Why no it's going to zero today? Loser. Hilda u r wrong evok will be YUGE!!!
  • V
    Vince
    Vince
    This is going to get lead footed up. Out of nowhere like before.
  • Y
    Yahoo Reader
    Yahoo Reader
    Nothing to prop the stock up until EOY it seems.
    it will continue it's downward slide
  • V
    Vince
    Vince
    Another thing with all that cash on hand you must admit the company spending less than 1.4 mil a quarter is extremely frugal. Definitely not burning thru cash!
  • V
    Vince
    Vince
    Pay Hildo pay! Back then then to the in home massage business with happy endings for all, I guess for you. Lol
  • P
    Pharmaherooooooo
    Pharmaherooooooo

    SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M /Undiscovered Stock/ Lots of Marketed Products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..Please do your own dd and realize the Monster Potential here .Thank me later

    Sonoma Pharma (Nasdaq: SNOA)

    Market Cap: 22.1 Million
    Cash: $12.6 Million
    Price: $5.15

    Shares Out : 4.3 Million

    Presentation
    http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf

    Fact Sheet
    http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf

    Driving to commercial EBITDAS breakeven, without dilution

    Grow current product portfolio with all sales people

    •Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
    •Mondoxyne for severe acne –launched late 2015
    •Ceramax for skin repair in atopic dermatitis–launched in April 2016
    •SebuDerm for seborrhea dermatitis –launched in November 2016

    Launch 3 New Products –our product pipeline –one every other quarter

    •Launching Loyon–Fall 2017
    •Ceramax in foam and gel forms –Q4 2017 & Q1 2018

    Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

    We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.

  • H
    Hilda
    Hilda
    Vice and M(orongoloid) are getting erect today. Will those 2 pumptards still be erect at the close when the price is $2.35? LOL
  • r
    rch1952
    rch1952
    stick that in your ear naysayers
  • o
    ocul
    ocul
    GURU4 minutes ago
    evok is like the kid who farted 💨 in class. Everyone knows about it and remembers the stink a year from now
  • V
    Vince
    Vince
    What a great CC! Total confidence moving forward. Wait till investors get wind of it and reposition investments. Ships take a while to turn!
  • n
    new
    new
    Hilda- why are you shorting this? i respect the shorts point of view as i learned not to fall in love with any stock so would appreciate your feedback.
  • V
    Vince
    Vince
    Oh Hildo, one more puppet show?
  • H
    Hilda
    Hilda
    Vince: tomorrow, this will plunge to the $2.30's. Bottom line: THIS HAD BETTER GET FULL FDA APPROVAL IN ORDER TO EVER GET TO $3.50, OR ELSE, THAT NITWIT IS GONNA HAVE THE WORD "MGMT" HANGING OUT HIS STINKWHOLE.
  • H
    Hilda
    Hilda
    Going down hard tomorrow!
  • n
    new
    new
    so tge PK trial started couple of days ago. will this be announced on Monday morning or after close